Chronic kidney disease

K Kalantar-Zadeh, TH Jafar, D Nitsch, BL Neuen… - The lancet, 2021 - thelancet.com
Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …

Dietary lipids, gut microbiota and lipid metabolism

M Schoeler, R Caesar - Reviews in endocrine and metabolic disorders, 2019 - Springer
The gut microbiota is a central regulator of host metabolism. The composition and function of
the gut microbiota is dynamic and affected by diet properties such as the amount and …

Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week

P Libby, J Loscalzo, PM Ridker, ME Farkouh… - Journal of the American …, 2018 - jacc.org
Observations on human and experimental atherosclerosis, biomarker studies, and now a
large-scale clinical trial support the operation of immune and inflammatory pathways in this …

Immune dysfunction and risk of infection in chronic kidney disease

M Syed-Ahmed, M Narayanan - Advances in chronic kidney disease, 2019 - Elsevier
Cardiovascular disease and infections are directly or indirectly associated with an altered
immune response, which leads to a high incidence of morbidity and mortality, and together …

ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities–role of gut microbiota dysbiosis

SD Viana, S Nunes, F Reis - Ageing research reviews, 2020 - Elsevier
Abstract Coronavirus disease 19 (COVID-19) is a pandemic condition caused by the new
coronavirus SARS-CoV-2. The typical symptoms are fever, cough, shortness of breath …

Plant-dominant low-protein diet for conservative management of chronic kidney disease

K Kalantar-Zadeh, S Joshi, R Schlueter, J Cooke… - Nutrients, 2020 - mdpi.com
Chronic kidney disease (CKD) affects> 10% of the adult population. Each year,
approximately 120,000 Americans develop end-stage kidney disease and initiate dialysis …

Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation?

H Fukui - Inflammatory intestinal diseases, 2016 - karger.com
Background: Increased intestinal permeability due to barrier dysfunction is supposed to
cause microbial translocation which may induce low-grade inflammation in various …

The gut microbiome, kidney disease, and targeted interventions

A Ramezani, DS Raj - Journal of the American Society of …, 2014 - journals.lww.com
The human gut harbors> 100 trillion microbial cells, which influence the nutrition,
metabolism, physiology, and immune function of the host. Here, we review the quantitative …

The role of gut microbiota in atherosclerosis and hypertension

J Ma, H Li - Frontiers in pharmacology, 2018 - frontiersin.org
In recent years, accumulating evidence has indicated the importance of gut microbiota in
maintaining human health. Gut dysbiosis is associated with the pathogenesis of a number of …

The immune system and kidney disease: basic concepts and clinical implications

C Kurts, U Panzer, HJ Anders, AJ Rees - Nature Reviews Immunology, 2013 - nature.com
The kidneys are frequently targeted by pathogenic immune responses against renal
autoantigens or by local manifestations of systemic autoimmunity. Recent studies in rodent …